Fresenius | FRE - Passivo Circulante





Passivo Circulante Alterar Data
Akzo Nobel EUR 4.39B 180M 2026-03
Alcon AG USD 3B 45M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
BASF EUR 16.41B 838M 2025-12
Bayer EUR 33.46B 875M 2026-03
Beiersdorf EUR 3.51B 261M 2025-12
DaVita Healthcare Partners USD 2.87B 274.18M 2026-03
Demant DKK 7.42B 1.63B 2025-12
E.ON EUR 29.49B 1.4B 2026-03
Essilor EUR 12.15B 766M 2025-12
Fresenius EUR 8.38B 1.18B 2025-12
Fresenius Medical Care EUR 6.73B 484.42M 2026-03
Getinge SEK 15.05B 169M 2024-12
Givaudan CHF 2.35B 422M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
GN Store Nord DKK 4.81B 2.5B 2026-03
GRIFOLS EUR 2.12B 105M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Lonza CHF 3.57B 421M 2025-12
Merck EUR 9.35B 307M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Philips EUR 7.43B 78M 2026-03
Roche Holding CHF 28B 421M 2025-12
RWE EUR 36.24B 13.31B 2026-03
Sanofi EUR 30.01B 1.66B 2026-03
Smith & Nephew USD 1.54B 236M 2025-12